Delivery Order SPE2DB22D2206-SPE2DB25FJM30
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of OFEV (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The order is scheduled for completion by August 11, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price arrangement. The contract, valued at $8,590.58, was competitively awarded without any set-aside designation and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules (60-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $8,590.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has an ultimate completion date of January 24, 2025, is for the supply of OFEV 150 MG CAPSULE 60S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OFEV 150 MG capsules. The firm-fixed-price contract, valued at $15,811.12, has a period of performance through November 26, 2024. This contract is a child order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules in a 60-count configuration. This competitive delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price pharmaceutical procurement to support federal medical supply needs. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM30Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This contract was competitively awarded on August 18, 2025, with a ceiling value of $17,181.16 and a firm fixed price structure. The delivery order is scheduled for completion by September 9, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No small business set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The OFEV order represents a specific pull from this master contract vehicle, which enables the company to deliver specialty pharmaceuticals, generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/18/25 |